Site Map – Ocular Therapeutix Skip to main content
Twitter LinkedIn Email
Ocular Therapeutix
  • About
    • Company
    • Hydrogel Technology
    • Leadership
      • Management Team
      • Board of Directors
      • Scientific Advisors
    • Clinical Trials
    • Contact Us
  • Pipeline
    • Retinal Diseases
      • OTX-TKI (axitinib intravitreal implant)
    • Glaucoma
      • OTX-TIC (travoprost intracameral implant)
    • Dry Eye Disease
      • OTX-CSI (cyclosporine intracanalicular insert)
      • OTX-DED (dexamethasone intracanalicular insert)
  • Products
    • DEXTENZA® (dexamethasone ophthalmic insert)
      • Postsurgical Ocular Inflammation and Pain
      • Ocular Itching Associated with Allergic Conjunctivitis
    • ReSure® Sealant
  • Investors
    • Press Releases
    • Events and Presentations
      • Upcoming & Past Events
      • Investor & Corporate Presentations
      • Scientific & Medical Presentations
    • SEC Filings
    • Corporate Governance
      • Board of Directors
      • Committee Composition
    • Stock Information
      • Analyst Coverage
      • Historical Price Lookup
      • Investment Calculator
    • Investor FAQs
    • Information Request
  • Careers
    • Culture and Values
    • Benefits
    • Open Positions
  • Search
Site Map

Site Map

  • Ocular Therapeutix
  • About
    • Company
    • Hydrogel Technology
    • Leadership
    • Contact Us
    • SCIENTIFIC ADVISORS
    • BOARD OF DIRECTORS
    • MANAGEMENT TEAM
  • Research
    • Pipeline
    • OTX-TIC (travoprost intracameral implant)
    • OTX-TKI (axitinib intravitreal implant)
    • Clinical Trials
    • OTX-CSI (cyclosporine intracanalicular insert)
    • OTX-DED (dexamethasone intracanalicular insert)
  • Products
    • DEXTENZA® (dexamethasone ophthalmic insert)
    • ReSure® Sealant
    • DEXTENZA® (dexamethasone ophthalmic insert) AC
  • Investors
  • Careers
    • Core Values + Benefits
    • Benefits
    • Company Culture and Values
  • Search
  • Privacy Policy
  • Terms and Conditions of Use
  • MEDICAL INQUIRIES
  • Social Media Consent
  • clinicaltrialsOTX-TIC
  • Clinical Trial Contact Form

Ocular Therapeutix Logo

© 2023 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA and ReSure are registered trademarks of Ocular Therapeutix, Inc.    PP-US-OTX-0004-V4

Privacy Policy | Terms of Use

The use of this Site is governed by its Terms of Use. The information contained in this Site is for informational purposes only. It is not a substitute for professional medical advice and should not be used to diagnose or treat any medical or health condition.

The contents of this Site are subject to change without notice. Ocular Therapeutix may modify and/or discontinue operation of all or portions of this Site at any time at its sole discretion without notice, and assumes no responsibility to update this Site. Ocular Therapeutix makes no representations or warranties with respect to the use of this Site or any information obtained herein.

As required by California Health & Safety Code Sections 119400-119402, Ocular has developed a comprehensive Compliance Program that is designed to comply with applicable federal and state laws and industry standards relating to the marketing and promotion of our products. To our knowledge as of the date of this declaration, Ocular Therapeutix, Inc. maintains compliance under our Compliance Program, as well as, with California Health & Safety Code sections 119400-119402. To request a copy of this declaration and a copy of Ocular Therapeutix’s Code of Conduct that provides an overview of our Compliance Program, please call 1-877-OTX-HELP.

Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset